Showing results (71-80 of 269) with videos related to
Sort By:
Pageof 27
European Journal of Nuclear Medicine and Molecular Imaging|July 12, 2003
Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinomaMarkus Luster, Steven I Sherman, Monica C Skarulis, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 14, 2009
Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomasSamuel Samnick, Bernd F Romeike, Thomas Lehmann, et al.The Journal of Clinical Endocrinology and Metabolism|May 27, 2011
I-131 activities as high as safely administrable (AHASA) for the treatment of children and adolescents with advanced differentiated thyroid cancerFrederik A Verburg, Johannes Biko, Stefanie Diessl, et al.Nursing & Health Sciences|July 5, 2016
Staffing and the incidence of pressure ulcers in German hospitals: A multicenter cross-sectional studyPaul Peter Schneider, Max GeraedtsEuropean Journal of Nuclear Medicine and Molecular Imaging|December 25, 2009
Dosimetry-guided high-activity (131)I therapy in patients with advanced differentiated thyroid carcinoma: initial experienceFrederik A Verburg, Heribert Hänscheid, Johannes Biko, et al.Medizinische Klinik (Munich, Germany : 1983)|May 16, 2009
[Role of TSH receptor autoantibodies for the diagnosis of Graves' disease and for the prediction of the course of hyperthyroidism and ophthalmopathy. Recommendations of the Thyroid Section of the German Society of Endocrinology]Anja Eckstein, Klaus Mann, George J Kahaly, et al.European Journal of Nuclear Medicine and Molecular Imaging|July 18, 2014
The number of 131I therapy courses needed to achieve complete remission is an indicator of prognosis in patients with differentiated thyroid carcinomaElena-Daphne Thies, Karina Tanase, Uwe Maeder, et al.The Journal of Clinical Endocrinology and Metabolism|November 15, 2012
Life expectancy is reduced in differentiated thyroid cancer patients ≥ 45 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patientsFrederik A Verburg, Uwe Mäder, Karina Tanase, et al.Applied and Environmental Microbiology|July 9, 2004
Use of fluorescent lectin probes for analysis of footprints from Pseudomonas aeruginosa MDC on hydrophilic and hydrophobic glass substrataEduardo Mora Bejarano, René Peter SchneiderZeitschrift Fur Kardiologie|September 1, 2004
[Piercing and tattoos in patients with congenital heart disease -- is it a problem?]Ingo Dähnert, Peter Schneider, Werner HandrickPageof 27